MFG
IMDX

Merit Financial Group’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Merit Financial Group’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,600
Closed -$7.36K – 770
2023
Q2 		$7.36K Hold
1,600
– – ﹤0.01% 737
2023
Q1 		$11.3K Hold
1,600
– – ﹤0.01% 624
2022
Q4 		$10.3K Buy
+1,600
New +$10.3K ﹤0.01% 684